Newsroom

Sorted by: Latest

-

SW Investors Have Opportunity to Join Smurfit Westrock Plc Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--SW Investors Have Opportunity to Join Smurfit Westrock Plc Fraud Investigation with SBS Law...
-

Palliser Capital Calls on LG Chem to Accelerate Value Enhancement Efforts and Strengthen Board Ahead of 2027 AGM

LONDON--(BUSINESS WIRE)--Palliser Capital ("Palliser"), one of the largest independent shareholders of LG Chem, Ltd. ("LG Chem" or the "Company"), today published a letter to the Company's Board of Directors welcoming its recent share buyback announcement, while calling for more ambitious and sustained action to address its persistent discount to net asset value ("NAV"), strengthen corporate governance and unlock long-term shareholder value. The letter follows almost three years of constructive...
-

GILT Investors Have Opportunity to Join Gilat Satellite Networks Ltd. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--GILT Investors Have Opportunity to Join Gilat Satellite Networks Ltd. Fraud Investigation with SBS Law...
-

IHRT Investors Have Opportunity to Join iHeartMedia, Inc. Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--IHRT Investors Have Opportunity to Join iHeartMedia, Inc. Fraud Investigation with SBS Law...
-

Investor Alert: Robbins LLP Informs Investors of the Intel Corporation Class Action Lawsuit

SAN DIEGO--(BUSINESS WIRE)--Intel Corporation faces allegations it misled investors about demand for its products and the Company's future growth potential....
-

Summit Therapeutics Provides Update Regarding Ivonescimab Biologics License Application

MIAMI--(BUSINESS WIRE)--Summit Therapeutics Inc. (NASDAQ: SMMT) today announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the Biologics License Application (BLA) for ivonescimab in combination with platinum-containing chemotherapy for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC), who have received prior epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) therapy....
-

GoGoMeds Appoints Harish Panchal as Chief Executive Officer

SOUTHGATE, Ky.--(BUSINESS WIRE)--GoGoMeds, a technology-enabled pharmacy specializing in prescription fulfillment, compounded medications, and direct-to-patient delivery, today announced the appointment of Harish Panchal as Chief Executive Officer. Panchal succeeds Cole Maudlin, whose leadership helped guide GoGoMeds through a period of significant growth and expanded capabilities.Panchal brings a strong commercial focus to the role, with a track record of shaping go-to-market strategy, growing...
-

Luvme Announces Black Friday Early Access: $140 Off + Price Protection

NEW YORK--(BUSINESS WIRE)--Luvme Hair is introducing its next Black Friday Early Access promotion, offering customers savings of up to $140 off qualifying orders alongside a new price protection initiative. Running from November 17 through November 26, 2026, the promotion features two shopping events designed to provide greater value and more confidence when shopping early. Black Friday Early Access: Up to $140 Off November 17–26, 2026 Under the theme “Black Friday Early Access | Up to $140 Off...
-

BA Investors Who Received Shares of The Boeing Company in Connection to Its Merger with Spirit AeroSystems Can Join Fraud Investigation with SBS Law

LOS ANGELES--(BUSINESS WIRE)--BA Investors Who Received Shares of The Boeing Company in Connection to Its Merger with Spirit AeroSystems Can Join Fraud Investigation with SBS Law...
-

INTC Investors Have Opportunity to Lead Intel Corporation Securities Fraud Lawsuit with SBS Law

LOS ANGELES--(BUSINESS WIRE)--INTC Investors Have Opportunity to Lead Intel Corporation Securities Fraud Lawsuit with SBS Law...